Septerna, Inc. Common Stock SEPN · Stock Open Septerna, Inc. Common Stock in new tab
Septerna, Inc. Common Stock Analysis (SEPN)
Is Septerna, Inc. Common Stock a good investment? Septerna, Inc. Common Stock (SEPN) is currently trading at 36.00 USD. Market analysts have a consensus price target of 54.22 USD. This suggests a potential upside from current levels.
Earnings Schedule: Septerna, Inc. Common Stock is expected to release its next earnings report on Nov. 9, 2026. The market consensus estimate for Forward EPS is -1.94.
Investor FAQ
Does Septerna, Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Septerna, Inc. Common Stock?
Septerna, Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 9, 2026. The company currently has a trailing EPS of -0.51.
Company Profile
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Community Discussion